CTSO Kronos AI forecast
A 30-trading-day price forecast for Cytosorbents Corporation (CTSO) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Cytosorbents Corporation at $6.67 on 2026-12-08, +37.5% from the last close of $4.85 on 2026-10-27. Eight out of ten sampled paths end between $5.91 and $7.20, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of CTSO
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $4.68 | $4.16 | $5.45 |
| 2026-11-10 | $5.50 | $4.78 | $6.05 |
| 2026-11-17 | $5.94 | $5.35 | $6.41 |
| 2026-11-24 | $6.36 | $5.76 | $6.74 |
| 2026-12-01 | $6.41 | $5.44 | $7.04 |
| 2026-12-08 | $6.67 | $5.91 | $7.20 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for CTSO?
- Kronos AI's median forecast for CTSO is $6.67 in 30 trading days, +37.5% from the last close, with a 10–90% range of $5.91 to $7.20.
- Is the CTSO Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- SYK — Stryker Corporation
- MMM — 3M Company
- BSX — Boston Scientific Corporation
- BDX — Becton Dickinson and Company
- MDLN — Medline Inc.
- RMD — ResMed Inc.